Nichi-Iko Pharmaceutical: Japan Industrial Solutions supports troubled local drug maker
Japan Industrial Solutions (JIS) has agreed to invest up to JPY 20bn (USD 155m) in Japan-based generic drug manufacturer Nichi-Iko Pharmaceutical with a view to saving the troubled company.
Read full article »
President & CEO
Yuichi Tamura
Nichi-Iko Pharmaceutical engages in manufacturing and commercializing prescription drugs issued by hospitals, clinics, pharmacies and drug stores.
Read more